Multicenter prospective randomized controlled clinical study of Apatinib combined with FLOT perioperative Chemotherapy and surgery for treatment of III stage Advanced Gastric Cancer

Trial Profile

Multicenter prospective randomized controlled clinical study of Apatinib combined with FLOT perioperative Chemotherapy and surgery for treatment of III stage Advanced Gastric Cancer

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Oct 2017

At a glance

  • Drugs Apatinib (Primary) ; Docetaxel; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Adenocarcinoma; Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top